Skip to main content
Home
  • Solutions
    Clinical solutions
    Blended Solutions Cardiac Safety Solutions Clinical & Scientific Operations Decentralised Clinical Trials Early Clinical Laboratories Medical Imaging Site & Patient Solutions Strategic Solutions
    Consulting & Commercial
    Asset Development Consulting Commercial Positioning Language Services Outcome Measures Real World Intelligence Regulatory Affairs Symphony Health data
    meeting
    Case studies

    Reducing time to market, delivering on quality, providing deep therapeutic expertise and enhancing R&D ROI.

    Innovative research tools showcase
    Technologies

    Technology solutions from early phase through to post-marketing.

  • Sectors
    Sectors

    ICON provides its full range of clinical, consulting and commercial services across several industry sectors.

    Read more
    Biotech Government and Public Health Medical Device Pharmaceuticals
    Biotechnology services navigation panel
    Biotech

    Developing transformative therapies requires a flexible approach.

    Employee engagement program overview
    ICON and You

    Partners making a difference.

  • Therapeutics
    Therapeutics
    Cardiovascular Central Nervous System Endocrine & Metabolic Disorders Hepatology Infectious Diseases Internal Medicine & Immunology Oncology
    Cross-therapeutics
    Biosimilars Cell and Gene Therapies Medical Device Pediatrics Rare & Orphan Diseases Vaccines Women's Health
    Obesity 2025 insights image
    Obesity

    A focus on combination therapies requires appropriate obesity-specific trial designs, long-term follow-up studies and diverse patient recruitment.

    Biological research visual element
    Therapeutics insights

    ICON's therapeutic experts contribute regularly to industry publications and the creation of thought leadership content. Read more.

  • Insights
    Insights
    Digital Disruption Patient Centricity Regulatory Intelligence Therapeutics insights Transforming Trials Value Based Healthcare Blog Videos Webinar Channel
    thumbnail
    Building a comparative evidence base using network meta-analysis

    Methods, implementation and reporting

    thumbnails
    Download 2025 Global and China biotech sector survey reports

    Two new reports of surveys of 260+ Global and China biotech leaders have just been released

    banners
    From bottlenecks to breakthroughs

    Human-centred strategies for faster study starts

  • News & Events
    News & Events

    ICON regularly contributes thought leadership to industry media publications and conferences, and has been recognised as one of the world’s leading Contract Research Organisations through a number of high-profile industry awards.

    Read more
    Press releases In the News Mediakit Awards Events Webinars Social media
    thumbnail
    ICH GCP E6(R3): Preparing for global implementation, assessing the impact, risk and requirements of the change

    Watch the webinar.

    data network
    Riding the data wave: How pharma can navigate disruptions in open claims

    Watch the webinar.

  • About ICON
    About ICON
    Company history ICON at a glance ICON in Asia Pacific ICON in Latin America Leadership Quality
    ICON for
    Patients Volunteers Investigators Jobs & Careers Investors Suppliers
    Responsible business practice indicators
    Sustainability, charity, inclusion and belonging

    ICON Cares is our commitment to making a positive impact on our people, environment and our community.

    Modern reception area at Dublin office
    ICON at a glance

    Delivering successful outcomes across the clinical development lifecycle.

  • Careers
  • Investors
  • Contact
  • 日本語
  • 简体中文
  1. Home
  2. News & Events
  3. Social media

Social media

Page tools
Share Share
Facebook

Share on Facebook

Facebook

Share on X

Facebook

Share on Linkedin

Bluesky

Share on Bluesky

Showing 481 - 492 of 1015 results for "*"

ICON Plc facebook post
ICON Plc logo
ICON Plc

Recognising ICON’s Environmental, Social & Governance (ESG) commitment through our ICON Cares programme, we are honoured to be named one of the world’s best by TIME/ Statista. This list ranks the world’s 500 most sustain...

13 Nov
4
Social media image
ICON Plc logo
ICON Plc

Recognising ICON’s Environmental, Social & Governance (ESG) commitment through our ICON Cares programme, we are honoured to be named one of the world’s best by TIME/ Statista. This list ranks the world’s 500 most susta...

13 Nov
Social media image
ICON Plc logo
ICON Plc

Today marks the final day of #OCTDACH, and our ICON team of experts is ready to welcome you at booth \#8. This is your chance to connect with leaders in clinical research and digital health who are driving innovation ac...

13 Nov
Social media image
ICON Plc logo
ICON Plc

Nearly 30 million adults in the U.S. live with obstructive sleep apnea (OSA) – a chronic condition requiring ongoing monitoring. Until now, clinicians lacked a validated patient-reported tool for tracking treatment respo...

12 Nov
ICON Plc facebook post
ICON Plc logo
ICON Plc

From imaging to cardiovascular care, AI-enabled devices are everywhere. But how do you navigate FDA regulations when there’s no unique pathway? Explore key insights on 510(k), De Novo, and lifecycle management in our new...

12 Nov
1
Social media image
ICON Plc logo
ICON Plc

From imaging to cardiovascular care, AI-enabled devices are everywhere. But how do you navigate FDA regulations when there’s no unique pathway? Explore key insights on 510(k), De Novo, and lifecycle management in our new...

12 Nov
ICON Plc facebook post
ICON Plc logo
ICON Plc

World Diabetes Day takes place on 14 November 2025. As the incidence of obesity and diabetes have grown in tandem to epidemic proportions, there is growing demand for treatments intended for patients with both conditions...

12 Nov
1
Social media image
ICON Plc logo
ICON Plc

World Diabetes Day takes place on 14 November. Read the article to find out how multi-indication drug development has gained traction due to a better understanding of glucose metabolism and its critical link to various d...

12 Nov
ICON Plc facebook post
ICON Plc logo
ICON Plc

Did you know? JCA findings aren’t binding—but they do shape national HTA decisions. Learn how to tailor your strategy for each EU market while staying aligned with JCA requirements. Download the whitepaper: https://ow.ly...

12 Nov
1
Social media image
ICON Plc logo
ICON Plc

Did you know? JCA findings aren’t binding—but they do shape national HTA decisions. Learn how to tailor your strategy for each EU market while staying aligned with JCA requirements. Download the whitepaper: https://ow.ly...

12 Nov
ICON Plc facebook post
ICON Plc logo
ICON Plc

Digital health technologies don’t just modernize clinical trials; they deliver measurable business value. From reducing trial timelines to improving patient retention and cutting costs, DHTs are proving their ROI across...

12 Nov
1
Social media image
ICON Plc logo
ICON Plc

For sponsors committed to leveraging digital measures in their protocol designs: How do you select the right digital measure? For those searching for a solution. ICON’s proprietary Atlas Network supports sponsors in sel...

12 Nov
  • Previous
  • 1
  • …
  • 40
  • 41
  • 42
  • …
  • 85
  • Next
Filter by:

Filter by:

Site Branding
    ICON plc
  • Contact
  • About ICON
  • Results & Reports
For Clients
  • Therapeutics
  • Solutions
  • Insights
  • Technologies
  • Content preferences
  • Office locations
ICON for
  • Patients
  • Volunteers
  • Investigators
  • Jobs & Careers
  • Investors
  • Suppliers
News & Events
  • Press releases
  • Mediakit
  • Events
  • Webinars
Socials
  • Linkedin
  • Facebook
  • Instagram
  • Youtube

Legal Footer

  • © 2026 ICON plc
  • Disclaimer
  • Privacy & Data
  • Cookies
How can we help?
  • All
  • Website
Popular search terms:
  • Biotech
  • Cell and Gene Therapies
  • Consulting
  • Early Clinical
  • Medical Device
  • Oncology
  • Rare & Orphan Diseases
  • Real World Evidence
  • Site & Patient Recruitment
  • Strategic Solutions
  • Regulatory Intelligence